Senate Medicaid Supplemental Rebate Amendment May Block PhRMA Suits
Executive Summary
An amendment to generic drug legislation in the Senate would eliminate the Pharmaceutical Research & Manufacturers of America's ability to challenge state Medicaid programs' use of supplemental drug rebates for residents not eligible for Medicaid
You may also be interested in...
GSK Selling Direct To Canadian Pharmacies, Auditing Orders To Curb Imports
GlaxoSmithKline is selling its products direct to pharmacies in Canada that are suspected by the company of selling to consumers in the U.S
GSK Selling Direct To Canadian Pharmacies, Auditing Orders To Curb Imports
GlaxoSmithKline is selling its products direct to pharmacies in Canada that are suspected by the company of selling to consumers in the U.S
GOP Victories Spell Relief On Rx Pricing; Will State Budgets Cause Heartburn?
Burgeoning state healthcare costs are likely to take center stage on Capitol Hill during debates over drug pricing and Medicare pharmacy benefit legislation in the new year